Tag: submission

Conference call and webcast scheduled for August 4, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST)

Vast majority of patients dosed completed the full 12-week study

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis.

FARGO, N.D., July 31, 2025 (GLOBE NEWSWIRE) -- Noridian Healthcare Solutions, LLC (Noridian), a leader in developing solutions for health care programs, is pleased to announce the North Dakota Health and Human Services has re-awarded Noridian the Medicaid Call Center contract, reaffirming Noridian’s role in elevating the state’s Medicaid program. This contract renewal extends Noridian’s partnership with North Dakota, ensuring continued high-quality service for Medicaid inquiries, including claims payment, claims submission and prior authorization.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY, OR CONSTITUTE A VIOLATION OF, THE RELEVANT LAWS OF THAT JURISDICTION OR REQUIRE EURONEXT AND/OR ATHEX TO TAKE ANY FURTHER ACTION.